Stress urinary incontinence (SUI) Urological and Genital Diseases
Conditions
Interventions
According to the random number table method, participants were divided into three groups: PFMT, PFMT + sacral, and PFMT + sacral + abdominal points, with 52 cases in each group.
Although the PFMT gr
Sponsors
Luohu Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female patients aged 30–75 years 2. Patients with symptoms conforming to the diagnosis standards of mild and moderate SUI 3. Patients conforming to the syndrome differentiation standards of urinary incontinence caused by kidney qi deficiency 4. Patients with normal routine examination results including those for urine and negative urine culture tests
Exclusion criteria
Exclusion criteria: 1. Patients with urge urinary incontinence or mixed urinary incontinence 2. Patients with a medical history of surgical treatment for urinary incontinence or pelvic surgery 3. Patients with uterine prolapse severity =Grade 2 4. Patients with symptomatic urinary system infection 5. Patients with residual urine volumes >30 ml 6. Patients with maximum uroflow rates <20 ml/s 7. Patients incapable of or with restricted capacity for walking, going upstairs/downstairs or running 8. Patients taking drugs that may affect their bladder function or receiving specific SUI treatment 9. Patients with SUI combined with multiple system atrophy, cauda equina lesions or myeleterosis 10. Patients who were pregnant or lactating 11. Patients fitted with cardiac pacemakers, sensitive to metals or with severe enetophobia 12. Patients with pelvic prolapse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measured at 6 weeks of treatment and 3 months follow up after treatment: 1. Basic patient information (age, height, body mass index, educational level, past medical history and delivery mode) measured using questionnaires 2. 1-hour pad test results measured by pad test | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. 1-hour pad test results measured by pad test at 2 weeks 4 weeks, 6 weeks of treatment and 18 weeks follow up after treatment 2. Times of urinary incontinence measured using International Consultation on Incontinence Questionnaire—Short Form (ICI-Q-SF) scores before treatment, during the 1-6 weeks of treatment and at 15-18 weeks follow up after treatment 3. Quality of life measured using Incontinence Quality of Life Instrument (I-QOL) scores before treatment, during the 1-6 weeks of treatment and at 15-18 weeks follow up after treatment 4. 72-hour urinary incontinence frequencies measured using pad test before treatment, during the 1-6 weeks of treatment and at 15-18 weeks follow up after treatment 5. Average pad usage per week measured using pad test before treatment, during the 1-6 weeks of treatment and at 15-18 weeks follow up after treatment | — |
Countries
China
Contacts
Public ContactNa-na Zhao
Outcome results
None listed